Γ

SynBioBeta Speaker

Inhwan Kim

CSO

Enveda

May 2026, SynBioBeta

Speaker

Inhwan Kim has diverse experience across provider, payor, and investor roles, which provides him with a unique cross-functional perspective at the intersection of science, finance, and healthcare strategy. Most recently, he managed the portfolio at BridgeBio, where he prioritized investments and ensured cohesive strategies across multiple drug development initiatives. Previously, he served as a consultant at McKinsey & Company, advising biotechs, pharmaceutical firms and global health authorities. Inhwan holds a Pharm.D. from Rutgers University and an MBA from The Kellogg School of Management at Northwestern University.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Previous Speakers Include

Join for the latest
SynBioBeta event updates.

Join for the latest SynBioBeta event updates.